Nadine Mothes

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi request reprint Allergy testing: the role of recombinant allergens
    Nadine Mothes
    Zentrum für Physiologie und Pathophysiologie, Institut fur Pathophysiologie, Abteilung Immunpathologie, Medizinische Universität Wien, Vienna, Austria
    Clin Chem Lab Med 44:125-32. 2006
  2. ncbi request reprint Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy
    Nadine Mothes
    Center for Physiology and Pathophysiology, Department of Pathophysiology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
    Int Arch Allergy Immunol 135:357-73. 2004
  3. ncbi request reprint Tree pollen allergens
    Nadine Mothes
    University of Vienna, Vienna Medical School, Vienna, Austria
    Clin Allergy Immunol 18:165-84. 2004
  4. ncbi request reprint Autoimmunity and atopic dermatitis
    Irene Mittermann
    Department of Pathophysiology, Division of Immunopathology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
    Curr Opin Allergy Clin Immunol 4:367-71. 2004
  5. ncbi request reprint Biology of tree pollen allergens
    Nadine Mothes
    Division of Immunopathology, Department of Pathophysiology, Vienna General Hospital, AKH, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Curr Allergy Asthma Rep 4:384-90. 2004
  6. ncbi request reprint Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy
    Thierry Batard
    Stallergènes, R and D, Antony, France
    Int Arch Allergy Immunol 136:239-49. 2005
  7. ncbi request reprint The cradle of IgE autoreactivity in atopic eczema lies in early infancy
    Nadine Mothes
    J Allergy Clin Immunol 116:706-9. 2005

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Allergy testing: the role of recombinant allergens
    Nadine Mothes
    Zentrum für Physiologie und Pathophysiologie, Institut fur Pathophysiologie, Abteilung Immunpathologie, Medizinische Universität Wien, Vienna, Austria
    Clin Chem Lab Med 44:125-32. 2006
    ..Besides their diagnostic application, recombinant allergens and hypoallergenic derivatives thereof have also been used as vaccines in clinical trials, and recent results have shown their usefulness for the treatment of type I allergy...
  2. ncbi request reprint Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy
    Nadine Mothes
    Center for Physiology and Pathophysiology, Department of Pathophysiology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
    Int Arch Allergy Immunol 135:357-73. 2004
    ..Information obtained by diagnostic testing with marker allergens will be important for the appropriate selection of patients for allergen-specific forms of therapy...
  3. ncbi request reprint Tree pollen allergens
    Nadine Mothes
    University of Vienna, Vienna Medical School, Vienna, Austria
    Clin Allergy Immunol 18:165-84. 2004
  4. ncbi request reprint Autoimmunity and atopic dermatitis
    Irene Mittermann
    Department of Pathophysiology, Division of Immunopathology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
    Curr Opin Allergy Clin Immunol 4:367-71. 2004
    ..This review summarizes evidence for autoimmune mechanisms in atopic dermatitis and suggests novel pathomechanisms that may be involved in this disease...
  5. ncbi request reprint Biology of tree pollen allergens
    Nadine Mothes
    Division of Immunopathology, Department of Pathophysiology, Vienna General Hospital, AKH, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Curr Allergy Asthma Rep 4:384-90. 2004
    ..Moreover, we describe novel recombinant allergen-based forms of specific immunotherapy...
  6. ncbi request reprint Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy
    Thierry Batard
    Stallergènes, R and D, Antony, France
    Int Arch Allergy Immunol 136:239-49. 2005
    ..We describe the production in Escherichia coli as a recombinant protein of clinical grade wild-type Bet v 1a (rBet v 1a), to be used as a candidate vaccine against birch pollen allergy...
  7. ncbi request reprint The cradle of IgE autoreactivity in atopic eczema lies in early infancy
    Nadine Mothes
    J Allergy Clin Immunol 116:706-9. 2005